QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PRTC

QT45PureTech Health plc
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
17.31
+0.45+2.67%
OverviewShort InterestFilings
PRTCQT45PureTech Health plc·NASDAQ
OverviewShort InterestFilings
17.31+2.67%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-1.10
Insider Own-
Shs Outstand243.42M
Perf Week2.67%
Market Cap421.39MForward P/E-EPS next Y-6.93Insider Trans-Shs Float-Perf Month-1.14%
Enterprise Value187.08MPEG0.00EPS next Q-1.16Inst Own-Short Float-Perf Quarter4.03%
Income-1104376375.00P/S90.65EPS this Y-488.18%Inst Trans-Short Ratio-Perf Half Y2.97%
Sales4.65MP/B0.13EPS next Y-7.11%ROA-20.48%Short Interest-Perf YTD4.03%
Book/sh1.26P/C-EPS next 5Y-ROE-31.83%52W High19.92 -13.10%Perf Year-10.08%
Cash/sh1.15P/FCF-EPS past 3/5Y-ROIC-19.64%52W Low14.50 19.38%Perf 3Y-
Dividend Est.-EV/EBITDA-1.97Sales past 3/5Y35.72% -8.97%Gross Margin-471.15%Volatility1.80% 3.01%Perf 5Y-
Dividend TTM-EV/Sales40.25EPS Y/Y TTM-1549.78%Oper. Margin-2115.41%ATR (14)0.52Perf 10Y-
Dividend Ex-Date-Quick Ratio6.59Sales Y/Y TTM520.00%Profit Margin-2355.50%RSI (14)50.55Recom2.00
Dividend Gr. 3/5Y-Current Ratio6.59EPS Q/Q-27209.64%SMA20-0.40%Beta0.68Target Price57.00
Payout0.00%Debt/Eq0.06Sales Q/Q-SMA500.00%Rel Volume0.11Prev Close16.86
Employees80LT Debt/Eq0.04EarningsAug 27SMA2000.74%Avg Volume9.61KPrice17.31
IPO DateNov 16, 2020Option/ShortYes / YesEPS/Sales Surpr.-1286.60% 50.00%Net Debt/EBITDA2.47Volume1,087Change2.67%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-25-22ReiteratedPiper SandlerOverweight$37 → $44
Aug-09-22ReiteratedLeerink Partners$66 → $70
Jun-15-22ReiteratedLeerink Partners$66
Jun-14-22ReiteratedPiper Sandler$72 → $37
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue3155
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A16534
Gross Profit-13551
Selling, General and Administrative Excl. Other1042127
Research and Development2724654
Other Operating Expense13659
Operating Income-361-99-136
Interest Expense114610
Unusual Expense
———
Non-Operating Income (Expense)-12-33-170
Net Income Before Taxes-43-11124
Income Taxes-23-1-4
Consolidated Net Income-61-11054
Net Income From Continuing Operations-18-11028
Net Income-61-11054
EPS (Recurring)-1.07-46.002.00
EPS (Basic, Before Extraordinaries)-1.07-46.002.00
EPS (Diluted)-1.10-46.002.00
EBITDA-130-6237
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio15.636.66—
Gross Margin-435.48100.0020.00
Operating Margin-1,164.52-1,980.00-2,720.00
Net Margin-196.77-2,200.001,080.00
Shares Outstanding28227
Market Capitalization48533—
Operating Lease Expense
———
Insider Trading Volume
$18.76$16.49$14.21$11.94$9.67● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR